Home/Filings/4/0000914190-09-000564
4//SEC Filing

PHILLIPS RICHARD BENTON 4

Accession 0000914190-09-000564

CIK 0001335102other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:17 PM ET

Size

12.2 KB

Accession

0000914190-09-000564

Insider Transaction Report

Form 4
Period: 2009-07-03
PHILLIPS RICHARD BENTON
Sr. VP Reg Affairs & QA
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-07-03$12.39/sh50,000$619,5000 total
    Exercise: $30.61Exp: 2019-01-22Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-07-03$8.91/sh60,000$534,6000 total
    Exercise: $34.09Exp: 2018-08-01Common Stock (60,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-07-03$38.50/sh60,000$2,310,0000 total
    Exercise: $4.50Exp: 2017-01-27Common Stock (60,000 underlying)
Footnotes (3)
  • [F1]This option to purchase shares of the Issuer's common stock, which provided for vesting in two equal annual installments commencing on the first anniversary of the date of grant, became 100% vested and exercisable due to a change in control of the Issuer effected through the completion of a tender offer by Kite Merger Sub, Inc. ("Kite"), a wholly-owned subsidiary of Johnson & Johnson, effective as of July 2, 2009. As a result of the completion of the tender office, this stock option was cancelled and the reporting person is entitled to a cash payment from the Issuer in the gross amount of $2,310,000.00, less applicable withholding, representing the difference between $43.00 (tender offer price) and the option exercise price for each share subject to this stock option.
  • [F2]This option to purchase shares of the Issuer's common stock, which provided for vesting in four equal annual installments commencing on the first anniversary of the date of grant, became 100% vested and exercisable due to a change in control of the Issuer effected through the completion of a tender offer by Kite, effective as of July 2, 2009. As a result of the completion of the tender offer, this stock option was cancelled and the reporting person is entitled to a cash payment from the Issuer in the gross amount of $534,600.00, less applicable withholding, representing the difference between $43.00 (tender offer price) and the option exercise price for each share subject to this stock option.
  • [F3]This option to purchase shares of the Issuer's common stock, which provided for vesting in four equal annual installments commencing on the first anniversary of the date of grant, became 100% vested and exercisable due to a change in control of the Issuer effected through the completion of a tender offer by Kite, effective as of July 2, 2009. As a result of the completion of the tender offer, this stock option was cancelled and the reporting person is entitled to a cash payment from the Issuer in the gross amount of $619,500.00, less applicable withholding, representing the difference between $43.00 (tender offer price) and the option exercise price for each share subject to this stock option.

Issuer

Cougar Biotechnology, Inc.

CIK 0001335102

Entity typeother

Related Parties

1
  • filerCIK 0001433384

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:17 PM ET
Size
12.2 KB